INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

78,999 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
281.3K sh
Mar 18, 2026Mar 20, 2026
Page 1308 of 1975
← PrevNext →
traded Mar 18, 2026
+2d
SEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
281.3K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

0
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Other acquisition or disposition · 10b5-1 plan
J—
60.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

57
MV
Maphai Thabane VincentDirector
SBSWSibanye Stillwater Ltd
Open-market purchase
BUY$160K
12.0K sh
Mar 16, 2026Mar 19, 2026
traded Mar 16, 2026
+3dSEC Form 4

Evidence

54
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Open-market sale · 10b5-1 plan
SELL$26.94M
1.79M sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

46
ZT
Zalatoris TimmiChief Human Resources Officer
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$784K
9,340 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

46
WB
Wahl BryanGeneral Counsel
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$284K
4,084 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

46
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$802K
11.7K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

46
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$802K
12.0K sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

46
MA
Mottiwala AzizChief Commercial Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$298K
4,286 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

46
BS
Blake SarahSVP, Chief Accounting Officer
VGVenture Global, Inc.
Open-market sale · 10b5-1 plan
SELL$3.20M
200.0K sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

45
LJ
Little Harrison JamesExecutive Vice President
KYNKayne Anderson Energy Infrastructure Fund, Inc.
Open-market purchase
BUY$71K
5,000 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

45
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Open-market sale · 10b5-1 plan
SELL$49.85M
3.21M sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

44
SA
Sfadia AdiCEO
GILTGILAT SATELLITE NETWORKS LTD
Open-market sale
SELL$632K
37.5K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

43
BB
Barker Richard B.EVP and CFO
NENoble Corp plc
Open-market sale
SELL$2.22M
47.2K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

43
BB
Barker Richard B.EVP and CFO
NENoble Corp plc
Open-market sale
SELL$4.77M
102.8K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

42
WB
Wahl BryanGeneral Counsel
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$283K
4,125 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

42
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$762K
11.0K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

42
NS
Neervannan SeshadriChief Operating Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$307K
4,589 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

42
WB
Wahl BryanGeneral Counsel
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$283K
4,231 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

42
WC
Whitfield Dianne C.Chief Human Resources Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$280K
4,174 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

42
MA
Mottiwala AzizChief Commercial Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$298K
4,330 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

42
SJ
Sinclair JackDirector, Chief Executive Officer
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$397K
4,754 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

42
WC
Whitfield Dianne C.Chief Human Resources Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$280K
4,071 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

42
MA
Mottiwala AzizChief Commercial Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$297K
4,440 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

42
WC
Whitfield Dianne C.Chief Human Resources Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$280K
4,029 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

42
LD
Lam DennisDirector
HFFGHF Foods Group Inc.
Open-market purchase
BUY$14K
8,000 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

42
TA
Tomasso Christopher AnthonyDirector, President and CEO
FWRGFirst Watch Restaurant Group, Inc.
Open-market sale
SELL$314K
25.1K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

41
SA
Sfadia AdiCEO
GILTGILAT SATELLITE NETWORKS LTD
Open-market sale
SELL$126K
7,500 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

41
SK
Schuyler KevinDirector
VEEETwin Vee PowerCats, Co.
Open-market purchase
BUY$10K
25.0K sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

40
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$25K
748 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

40
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$42K
1,274 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

40
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$34K
1,033 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

40
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$31K
922 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

39
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$55K
1,762 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

39
EW
Eifler Robert W.Director, President & CEO
NENoble Corp plc
Open-market sale
SELL$3.38M
72.8K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

39
NS
Neervannan SeshadriChief Operating Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$217K
3,125 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

39
KN
Konat NicholasPresident & COO
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$79K
952 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

39
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$68K
2,173 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

39
HD
Hamilton DustinChief Stores Officer
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$85K
1,017 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence